Demonising Justin Gatlin
13th September 2015
The Canadian Centre for Ethics in Sport (CCES) announced today that Ian Chan, a wheelchair rugby athlete, received a sanction of 16 months for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on December 13, 2014, revealed the presence of oxycodone and fentanyl.
Oxycodone and fentanyl are classified as ‘specified substances’ on the World Anti-Doping Agency Prohibited List. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a ‘specified substance’ can seek to have the sanction reduced to a reprimand.
In response to the CCES’ notification of the adverse analytical finding, Mr. Chan acknowledged the anti-doping rule violation and a hearing was held to determine whether the two-year period of ineligibility should be eliminated or reduced. Arbitrator Carol Roberts imposed a sanction of 16 months ineligibility from sport, terminating April 13, 2016.
In response to the arbitrator’s decision, Mr. Chan appealed to the Court of Arbitration for Sport (CAS). On December 11, 2015, after assessing the athlete’s degree of fault, the CAS Appeal Panel upheld the 16 month sanction period imposed by Arbitrator Roberts. The athlete, who resides in Richmond, British Columbia, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates for the duration of his period of ineligibility, subject to the provisions of the CADP regarding a limited return to training.
• This media release was originally published by the Canadian Centre for Ethics in Sport (CCES) on 23 December 2015. To access the original, please click here.
Athletes who lie to doping control personnel about having symptoms of Covid-19 could face a...